A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials to Assess the Risk of Pneumonia, URTIs, and VTE in Multiple Myeloma Patients Treated with Isatuximab

Authors

D. T. Jones
H. Aboaid
R. Srinvasmurthy
K. Nguyen
R. K. Nanda
J. Ta
B. T. Chuang
Y. M. Myat
A. Hanspal
Kyaw Z. Thein, Touro University NevadaFollow
T. W. Htut

Roles

Author

Document Type

Article

Publication Date

1-1-2025

Publication Title

Exploration of Targeted Anti-tumor Therapy

DOI

10.37349/etat.2025.1002300

Recommended Citation

Jones, D. T., Aboaid, H., Srinvasmurthy, R., Nguyen, K., Nanda, R. K., Ta, J., Chuang, B. T., Myat, Y. M., Hanspal, A., Thein, K. Z., & Htut, T. W. (2025). A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials to Assess the Risk of Pneumonia, URTIs, and VTE in Multiple Myeloma Patients Treated with Isatuximab. Exploration of Targeted Anti-tumor Therapy, 6. https://doi.org/10.37349/etat.2025.1002300